Skip to Navigation | Skip to Main Content | Skip to Site Map

MyFloridaHouse.gov | Flsenate.gov Archives | Mobile Site

Senate Tracker: Sign Up | Login

Updates to this website are being made to reflect the results of the General Election.

CS/CS/HB 269: Experimental Treatments for Terminal Conditions

GENERAL BILL by Insurance and Banking Subcommittee ; Health Innovation Subcommittee ; Pilon ; (CO-INTRODUCERS) Adkins ; Ahern ; Albritton ; Artiles ; Drake ; Dudley ; Edwards ; Eisnaugle ; Harrison ; Magar ; Mayfield ; Stevenson ; Wood

Experimental Treatments for Terminal Conditions; Provides conditions for manufacturer to provide certain drugs, products, or devices to eligible patient; specifies insurance coverage requirements & exceptions; provides conditions for provision of certain services by hospital or health care facility; provides immunity from liability; provides protection from disciplinary or legal action against physician who makes certain treatment recommendations; provides that cause of action may not be asserted against manufacturer of certain drugs, products, or devices or person or entity caring for patient using such drug, product, or device under certain circumstances; provides applicability.

Effective Date: 7/1/2015
Last Action: 6/11/2015 - Chapter No. 2015-107
Location: Became Law
Bill Text: PDF



Bill History

Date Chamber Action
1/14/2015 House • Filed
1/22/2015 House • Referred to Health Innovation Subcommittee; Insurance and Banking Subcommittee; Health and Human Services Committee -HJ 26
3/3/2015 House • Introduced -HJ 26
3/6/2015 House • On Committee agenda-- Health Innovation Subcommittee, 03/10/15, 9:00 am, 306 HOB
3/10/2015 House • CS by Health Innovation Subcommittee; YEAS 12 NAYS 0 -HJ 216
3/11/2015 House • Pending review of CS under Rule 7.19(c)
• CS by Health Innovation Subcommittee read 1st time -HJ 212
3/12/2015 House • Now in Insurance and Banking Subcommittee -HJ 222
3/23/2015 House • On Committee agenda-- Insurance and Banking Subcommittee, 03/25/15, 8:00 am, Sumner Hall
3/25/2015 House • CS/CS by Insurance and Banking Subcommittee; YEAS 12 NAYS 0 -HJ 330
3/26/2015 House • Pending review of CS under Rule 7.19(c)
• CS/CS by Insurance and Banking Subcommittee read 1st time -HJ 319
3/27/2015 House • Now in Health and Human Services Committee -HJ 343
3/30/2015 House • On Committee agenda-- Health and Human Services Committee, 04/01/15, 8:30 am, Morris Hall
4/1/2015 House • Favorable by- Health and Human Services Committee; YEAS 16 NAYS 0 -HJ 364
• Placed on Calendar -HJ 364
4/13/2015 House • Placed on Special Order Calendar, 04/15/15
4/15/2015 House • Read 2nd time -HJ 540
• Placed on 3rd reading
4/16/2015 House • Read 3rd time -HJ 566
• CS passed; YEAS 113 NAYS 0 -HJ 566
4/21/2015 Senate • In Messages
• Referred to Health Policy; Appropriations Subcommittee on Health and Human Services; Fiscal Policy -SJ 444
• Received -SJ 444
4/27/2015 Senate • Withdrawn from Health Policy; Appropriations Subcommittee on Health and Human Services; Fiscal Policy -SJ 670
• Placed on Calendar, on 2nd reading -SJ 670
• Substituted for CS/CS/SB 1052 -SJ 670
• Read 2nd time -SJ 670
• Placed on 3rd reading
4/28/2015 Senate • Read 3rd time -SJ 700
• CS passed; YEAS 39 NAYS 1 -SJ 700
4/28/2015 House • Ordered enrolled -HJ 913
5/26/2015 • Signed by Officers and presented to Governor
6/10/2015 • Approved by Governor
6/11/2015 • Chapter No. 2015-107